| Pooja Chaukiyal, MD | |
|
43 New Scotland Ave, Mail Code 7, Albany, NY 12208-3412 | |
| (518) 262-6696 | |
| (518) 262-6770 |
| Full Name | Pooja Chaukiyal |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 27 Years |
| Location | 43 New Scotland Ave, Albany, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659414761 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 277961 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Albany Medical Center Hospital | Albany, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York Oncology Hematology Pc | 3072406222 | 72 |
News Archive
Neovasc Inc. today announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration to initiate the U.S. arm of its TIARA-I Early Feasibility Trial for the Company's Tiara™ transcatheter mitral valve.
The study of these unique substances in each of us paves the way for a revolution in the treatment and prevention of diseases, allowing for early diagnosis and increasingly targeted pharmacological treatments.
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
In experiments with fruit flies, Johns Hopkins researchers have discovered how a key light-detecting molecule in the eye moves in response to changes in light intensity.
› Verified 6 days ago
| Entity Name | New York Oncology Hematology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609863448 PECOS PAC ID: 3072406222 Enrollment ID: O20040203000652 |
News Archive
Neovasc Inc. today announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration to initiate the U.S. arm of its TIARA-I Early Feasibility Trial for the Company's Tiara™ transcatheter mitral valve.
The study of these unique substances in each of us paves the way for a revolution in the treatment and prevention of diseases, allowing for early diagnosis and increasingly targeted pharmacological treatments.
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
In experiments with fruit flies, Johns Hopkins researchers have discovered how a key light-detecting molecule in the eye moves in response to changes in light intensity.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pooja Chaukiyal, MD 43 New Scotland Ave, Mail Code 7, Albany, NY 12208-3412 Ph: (518) 262-6696 | Pooja Chaukiyal, MD 43 New Scotland Ave, Mail Code 7, Albany, NY 12208-3412 Ph: (518) 262-6696 |
News Archive
Neovasc Inc. today announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration to initiate the U.S. arm of its TIARA-I Early Feasibility Trial for the Company's Tiara™ transcatheter mitral valve.
The study of these unique substances in each of us paves the way for a revolution in the treatment and prevention of diseases, allowing for early diagnosis and increasingly targeted pharmacological treatments.
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
In experiments with fruit flies, Johns Hopkins researchers have discovered how a key light-detecting molecule in the eye moves in response to changes in light intensity.
› Verified 6 days ago
Arunima Rajbhandary, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1550 | |
Dr. Rahul Ravilla, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 43 New Scotland Ave Ste 7, Albany, NY 12208 Phone: 518-262-6696 Fax: 518-262-2624 | |
Emmanuelle Cordero Torres, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave Dept Of Nephrology, Albany Medical Center, Albany, NY 12208 Phone: 518-262-5377 | |
Nancy Shrestha, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5 Palisades Dr Ste 200, Albany, NY 12205 Phone: 518-471-3636 Fax: 518-471-3668 | |
Stephen Hillinger, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 400 Patroon Creek Blvd, Suite 1, Albany, NY 12206 Phone: 518-489-0044 Fax: 518-489-3591 | |
Louis H Gold, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5 Palisades Dr, Ste100, Albany, NY 12205 Phone: 518-438-4496 | |
Sean Joseph Sheehan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1375 Washington Ave, Suite 101, Albany, NY 12206 Phone: 518-438-4483 Fax: 518-482-4201 |